Journal of Korean Neurosurgical Society

  • 제59권1호
  • /
  • Pages.44-51
  • /
  • 2016
  • /
  • 2005-3711(pISSN)
  • /
  • 1598-7876(eISSN)
대한신경외과학회 (The Korean Neurosurgical Society)
권호 표지
DOI QR코드

DOI QR Code

Malignant Glioma with Neuronal Marker Expression : A Clinicopathological Study of 18 Cases

  • Kim, Hong Rye (Department of Neurosurgery, Konyang University Hospital, Konyang University School of Medicine) ;
  • Lee, Jae Jun (Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Lee, Jung-Il (Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Nam, Do Hyun (Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Suh, Yeon-Lim (Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Seol, Ho Jun (Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • 투고 : 2015.07.02
  • 심사 : 2015.12.18
  • 발행 : 2016.01.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objective : Malignant gliomas with neuronal marker expression (MGwNM) are rare and poorly characterized. Increasingly diverse types of MGwNM have been described and these reported cases underscore the dilemmas in the classification and diagnosis of those tumors. The aim of this study is to provide additional insights into MGwNM and present the clinicopathological features of 18 patients. Methods : We reviewed the medical records of 18 patients diagnosed as MGwNM at our institute between January 2006 and December 2012. Macroscopic total resection was performed in 11 patients (61%). We evaluated the methylation status of $O^6$-methylguanine-DNA methyltransferase (MGMT) and expression of isocitrate dehydrogenase 1 (IDH-1) in all cases, and deletions of 1p and 19q in available cases. Results : The estimated median overall survival was 21.2 months. The median progression-free survival was 6.3 months. Six patients (33%) had MGMT methylation but IDH1 mutation was found in only one patient (6%). Gene analysis for 1p19q performed in nine patients revealed no deletion in six, 19q deletion only in two, and 1p deletion only in one. The extent of resection was significantly correlated with progression free survival on both univariate analysis and multivariate analysis (p=0.002 and p=0.013, respectively). Conclusion : In this study, the overall survival of MGwNM was not superior to glioblastoma. The extent of resection has a significant prognostic impact on progression-free survival. Further studies of the prognostic factors related to chemo-radio therapy, similar to studies with glioblastoma, are mandatory to improve survival.

키워드

참고문헌

  1. Aouba A, Dezamis E, Sermet A, Rothschild C, Hermine O, Lasne D, et al. : Uncomplicated neurosurgical resection of a malignant glioneuronal tumour under haemostatic cover of rFVIIa in a severe haemophilia patient with a high-titre inhibitor : a case report and literature review of rFVIIa use in major surgeries. Haemophilia 16 : 54-60, 2010
  2. Aryan HE, Overstreet KL, Amjadi DK, Hansen LA : Primary anaplastic glio-neuronal tumor of the pineal gland : a new type of pineal neoplasm? J Clin Neurosci 11 : 163-165, 2004 https://doi.org/10.1016/j.jocn.2003.08.004
  3. Balss J, Meyer J, Mueller W, Korshunov A, Hartmann C, von Deimling A : Analysis of the IDH1 codon 132 mutation in brain tumors. Acta Neuropathol 116 : 597-602, 2008 https://doi.org/10.1007/s00401-008-0455-2
  4. Biernat W, Zakrzewski K, Polis L, Liberski PP : Glioneuronal-mesenchymal tumour with malignant transformation. Folia Neuropathol 45 : 140-143, 2007
  5. Brat DJ, Parisi JE, Kleinschmidt-DeMasters BK, Yachnis AT, Montine TJ, Boyer PJ, et al. : Surgical neuropathology update : a review of changes introduced by the WHO classification of tumours of the central nervous system, 4th edition. Arch Pathol Lab Med 132 : 993-1007, 2008
  6. Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR, et al. : Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 90 : 1473-1479, 1998 https://doi.org/10.1093/jnci/90.19.1473
  7. Courville CB : Ganglioglioma tumor of the central nervous system : review of the literature and report of two cases. Arch Neurol Psychiatr 24 : 439-491, 1930 https://doi.org/10.1001/archneurpsyc.1930.02220150002001
  8. DeWire MD, Beltran C, Boop FA, Helton KJ, Ellison DW, McKinnon PJ, et al. : Radiation therapy and adjuvant chemotherapy in a patient with a malignant glioneuronal tumor and underlying ataxia telangiectasia : a case report and review of the literature. J Clin Oncol 31 : e12-e14, 2013 https://doi.org/10.1200/JCO.2011.40.1430
  9. Esteller M, Garcia-Foncillas J, Andion E, Goodman SN, Hidalgo OF, Vanaclocha V, et al. : Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 343 : 1350-1354, 2000 https://doi.org/10.1056/NEJM200011093431901
  10. Hegi ME, Diserens AC, Godard S, Dietrich PY, Regli L, Ostermann S, et al. : Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide. Clin Cancer Res 10 : 1871-1874, 2004 https://doi.org/10.1158/1078-0432.CCR-03-0384
  11. Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, et al. : MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352 : 997-1003, 2005 https://doi.org/10.1056/NEJMoa043331
  12. Intergroup Radiation Therapy Oncology Group Trial 94021, Cairncross G, Berkey B, Shaw E, Jenkins R, Scheithauer B, et al. : Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma : Intergroup Radiation Therapy Oncology Group Trial 9402. J Clin Oncol 24 : 2707-2714, 2006 https://doi.org/10.1200/JCO.2005.04.3414
  13. Kaloostian PE, Chen H, Tran HP : Malignant papillary glioneuronal tumor of the pineal gland : case presentation and literature review of a distinct entity. Am J Case Rep 14 : 164-168, 2013 https://doi.org/10.12659/AJCR.883919
  14. McLendon RE, Bentley RC, Parisi JE, Tien RD, Harrison JC, Tarbell NJ, et al. : Malignant supratentorial glial-neuronal neoplasms : report of two cases and review of the literature. Arch Pathol Lab Med 121 : 485-492, 1997
  15. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, et al. : An integrated genomic analysis of human glioblastoma multiforme. Science 321 : 1807-1812, 2008 https://doi.org/10.1126/science.1164382
  16. Rodriguez FJ, Scheithauer BW, Port JD : Unusual malignant glioneuronal tumors of the cerebrum of adults : a clinicopathologic study of three cases. Acta Neuropathol 112 : 727-737, 2006 https://doi.org/10.1007/s00401-006-0129-x
  17. Rodriguez FJ, Scheithauer BW, Robbins PD, Burger PC, Hessler RB, Perry A, et al. : Ependymomas with neuronal differentiation : a morphologic and immunohistochemical spectrum. Acta Neuropathol 113 : 313-324, 2007 https://doi.org/10.1007/s00401-006-0153-x
  18. Shibahara J, Fukayama M : Secondary glioblastoma with advanced neuronal immunophenotype. Virchows Arch 447 : 665-668, 2005 https://doi.org/10.1007/s00428-005-1263-x
  19. Takeuchi H, Kubota T, Kitai R, Matsuda K, Hashimoto N, Sato K : Chromosome 1p and 19q deletions in malignant glioneuronal tumors with oligodendroglioma-like component. J Neurooncol 91 : 33-38, 2009 https://doi.org/10.1007/s11060-008-9690-6
  20. Tamber MS, Rutka JT : Pediatric supratentorial high-grade gliomas. Neurosurg Focus 14 : e1, 2003
  21. Tihan T, Gultekin H, Comunoglu N : Glioneuronal neoplasms with malignant histological features : a study of 36 cases. Turk J Pathol 26 : 55-67, 2010 https://doi.org/10.5146/tjpath.2010.00996
  22. Varlet P, Soni D, Miquel C, Roux FX, Meder JF, Chneiweiss H, et al. : New variants of malignant glioneuronal tumors : a clinicopathological study of 40 cases. Neurosurgery 55 : 1377-1391; discussion 1391-1392, 2004 https://doi.org/10.1227/01.NEU.0000143033.36582.40
  23. Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, et al. : IDH1 and IDH2 mutations in gliomas. N Engl J Med 360 : 765-773, 2009 https://doi.org/10.1056/NEJMoa0808710

피인용 문헌

  1. A comparative histopathological and immunohistochemical study of Survivin and Ki-67 proteins in glial tumours vol.33, pp.1, 2019, https://doi.org/10.1080/13102818.2019.1591931
  2. Identification of relevant genetic alterations in cancer using topological data analysis vol.11, pp.1, 2016, https://doi.org/10.1038/s41467-020-17659-7